These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 22676700

  • 1. Accuracy of distortion-product otoacoustic emissions-based ototoxicity monitoring using various primary frequency step-sizes.
    McMillan GP, Konrad-Martin D, Dille MF.
    Int J Audiol; 2012 Sep; 51(9):689-96. PubMed ID: 22676700
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Otoacoustic emissions measurements in children during the chemotherapy because of the acute lymphoblastic leukemia].
    Lisowska G, Namysłowski G, Hajduk A, Polok A, Tomaszewska R, Misiołek M.
    Otolaryngol Pol; 2006 Sep; 60(3):415-20. PubMed ID: 16989457
    [Abstract] [Full Text] [Related]

  • 7. Ototoxicity risk assessment combining distortion product otoacoustic emissions with a cisplatin dose model.
    Dille MF, McMillan GP, Reavis KM, Jacobs P, Fausti SA, Konrad-Martin D.
    J Acoust Soc Am; 2010 Sep; 128(3):1163-74. PubMed ID: 20815453
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Monitoring of cisplatin ototoxicity by distortion-product otoacoustic emissions.
    Ozturan O, Jerger J, Lew H, Lynch GR.
    Auris Nasus Larynx; 1996 Sep; 23():147-51. PubMed ID: 8809338
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Early changes in auditory function as a result of platinum chemotherapy: use of extended high-frequency audiometry and evoked distortion product otoacoustic emissions.
    Knight KR, Kraemer DF, Winter C, Neuwelt EA.
    J Clin Oncol; 2007 Apr 01; 25(10):1190-5. PubMed ID: 17401008
    [Abstract] [Full Text] [Related]

  • 16. Cisplatin ototoxicity in the Sprague Dawley rat evaluated by distortion product otoacoustic emissions.
    Hatzopoulos S, Di Stefano M, Campbell KC, Falgione D, Ricci D, Rosignoli M, Finesso M, Albertin A, Previati M, Capitani S, Martini A.
    Audiology; 2001 Apr 01; 40(5):253-64. PubMed ID: 11688544
    [Abstract] [Full Text] [Related]

  • 17. Characteristics and risk factors of cisplatin-induced ototoxicity in testicular cancer patients detected by distortion product otoacoustic emission.
    Biro K, Noszek L, Prekopp P, Nagyiványi K, Géczi L, Gaudi I, Bodrogi I.
    Oncology; 2006 Apr 01; 70(3):177-84. PubMed ID: 16757924
    [Abstract] [Full Text] [Related]

  • 18. Effect of cisplatin chemotherapy on the inner ear function and serum prestin concentration.
    Jalali MM, Saedi HS, Saadat F.
    Eur Arch Otorhinolaryngol; 2022 Jun 01; 279(6):2783-2789. PubMed ID: 34213608
    [Abstract] [Full Text] [Related]

  • 19. The statistical basis for serial monitoring in audiology.
    McMillan GP, Reavis KM, Konrad-Martin D, Dille MF.
    Ear Hear; 2013 Sep 01; 34(5):610-8. PubMed ID: 23563060
    [Abstract] [Full Text] [Related]

  • 20. Distortion-product otoacoustic emissions in middle-aged subjects with normal versus potentially presbyacusic high-frequency hearing loss.
    Nieschalk M, Hustert B, Stoll W.
    Audiology; 1998 Sep 01; 37(2):83-99. PubMed ID: 9547922
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.